INTCHIGH SIGNALFINANCIAL10-K

Intel achieved a dramatic 98.6% improvement in net losses from -$18.8B to -$267M, while significantly strengthening its balance sheet with 73% higher cash reserves and reduced capital expenditures.

This represents a massive operational turnaround for Intel, moving from catastrophic losses to near break-even while building a substantial cash cushion of $14.3B. The company appears to have executed a successful cost reduction strategy, cutting R&D and SG&A expenses by 16-17% while maintaining positive operating cash flow, though the 39% reduction in capex may signal reduced investment in future growth.

Comparing 2026-01-23 vs 2025-01-31View on EDGAR →
FINANCIAL ANALYSIS

Intel demonstrated remarkable financial recovery with net losses improving by $18.5B to near break-even levels, while operating losses narrowed by 81% to -$2.2B despite higher interest expenses. The company strengthened its balance sheet significantly with cash increasing 73% to $14.3B and stockholders' equity growing 15% to $114.3B, funded partly by a 39% reduction in capital expenditures from $23.9B to $14.6B. This reflects a successful cost-cutting turnaround strategy that has stabilized operations and rebuilt financial flexibility, though the dramatic capex reduction raises questions about future competitive positioning.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+98.6%
-$18.8B-$267.0M

Net income grew 98.6% — bottom-line growth signals improving overall business health.

Operating Income
P&L
+81%
-$11.7B-$2.2B

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Interest Expense
P&L
+77%
$496.0M$878.0M

Interest expense surged 77% — significant debt increase or rising rates materially impacting earnings.

Cash & Equivalents
Balance Sheet
+72.9%
$8.2B$14.3B

Cash position surged 72.9% — strong cash generation or capital raise providing significant financial cushion.

Capital Expenditure
Cash Flow
-38.8%
$23.9B$14.6B

Capex reduced 38.8% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Current Assets
Balance Sheet
+34.6%
$47.3B$63.7B

Current assets grew 34.6% — improving short-term liquidity or inventory/receivables build.

Operating Cash Flow
Cash Flow
+17%
$8.3B$9.7B

Operating cash flow grew 17% — strong conversion of earnings to cash, healthy business fundamentals.

R&D Expense
P&L
-16.8%
$16.5B$13.8B

R&D spending cut 16.8% — could signal cost discipline or concerning reduction in innovation investment.

SG&A Expense
P&L
-16%
$5.5B$4.6B

SG&A reduced 16% — improved cost efficiency or headcount reduction improving operating margins.

Stockholders Equity
Balance Sheet
+15.1%
$99.3B$114.3B

Equity base grew 15.1% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-01-23
PRIOR — 2025-01-31
ADDED
4,995 million shares of common stock were outstanding as of January 16, 2026.
The preparation of our Consolidated Financial Statements is in conformity with U.S.
Our Form 10-K includes Adjusted Free Cash Flow, a non-GAAP financial measure we use to evaluate the cash flow trends of our business.
See "Liquidity and Capital Resources" within MD A for a description of this measure, including why management uses it and why we believe it provides investors with useful supplemental information.
government's acquisition of significant equity interests in us; changes in product demand and margins; macroeconomic conditions and geopolitical tensions and conflicts, including geopolitical and trade tensions between the U.S.
We believe these third-party reports to be reputable, but have not independently verified the underlying data sources, methodologies or assumptions.
Intel, Arc, Intel Core, FlexRAN, Gaudi, the Intel logo, Thunderbolt and the Thunderbolt logo, Intel vPro and Xeon are trademarks of Intel Corporation or its subsidiaries.
2 Overview We are a global designer and manufacturer of semiconductor products.
Our customers primarily include OEMs, ODMs, CSPs, and other manufacturers and service providers, such as industrial and communication equipment manufacturers.
We market and sell our products through a combination of direct sales through our global sales organization and indirect channels, including distributors, resellers, retailers and OEM partners.
REMOVED
4,330 million shares of common stock were outstanding as of January 24, 2025.
The preparation of our Consolidated Financial Statements is in conformity with US GAAP.
Our Form 10-K includes key metrics that we use to measure our business, some of which are non-GAAP measures.
See "Non-GAAP Financial Measures" within MD A for an explanation of these measures and why management uses them and believes they provide investors with useful supplemental information.
Intel believes these third-party reports to be reputable, but has not independently verified the underlying data sources, methodologies, or assumptions.
Intel, Arc, Intel Atom, Intel Core, Intel Evo, FlexRAN, Gaudi, the Intel logo, Intel Optane, MAX, Movidius, OpenVINO, the OpenVINO logo, Thunderbolt and the Thunderbolt logo, Intel vPro, and Xeon are trademarks of Intel Corporation or its subsidiaries.
2 Fundamentals of Our Business We are a global designer and manufacturer of semiconductor products.
Customers of our semiconductor products primarily include OEMs, ODMs, cloud service providers, and other manufacturers and service providers, such as industrial and communication equipment manufacturers and other cloud service providers who buy our products through distributor, reseller, retail, and OEM channels throughout the world.
We market and sell our semiconductor products directly through our global sales and marketing organizations and indirectly through channel partners.
We also develop semiconductor fabrication process and packaging technologies and manufacture many of our semiconductor product offerings at our geographically diverse network of fabrication and assembly and test facilities.
MORE FINANCIAL SIGNALS
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD substantially expanded R&D spending while introducing new product Yeztugo f...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →